Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.2000
- TODAY'S CHANGE (%)-0.0700 (-2.1407%)
- Bid / Lots3.1000/ 3
- Ask / Lots3.2200/ 19
- Open / Previous Close3.2700 / 3.2700
- Day Range
- 52 Week Range
- Volume439,240
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 4932 | 3.245 |
| 09:34 ET | 5973 | 3.22 |
| 09:36 ET | 13770 | 3.19 |
| 09:38 ET | 6988 | 3.19 |
| 09:39 ET | 13577 | 3.2 |
| 09:41 ET | 100 | 3.175 |
| 09:43 ET | 1782 | 3.18 |
| 09:45 ET | 2700 | 3.165 |
| 09:48 ET | 3571 | 3.14 |
| 09:50 ET | 200 | 3.135 |
| 09:52 ET | 850 | 3.135 |
| 09:54 ET | 1187 | 3.1196 |
| 09:56 ET | 1411 | 3.118 |
| 09:57 ET | 1399 | 3.12 |
| 09:59 ET | 1099 | 3.12 |
| 10:01 ET | 5555 | 3.125 |
| 10:03 ET | 800 | 3.13 |
| 10:08 ET | 2200 | 3.14 |
| 10:10 ET | 1000 | 3.138 |
| 10:12 ET | 1031 | 3.1368 |
| 10:14 ET | 650 | 3.1309 |
| 10:15 ET | 1000 | 3.1362 |
| 10:17 ET | 6373 | 3.155 |
| 10:21 ET | 500 | 3.158 |
| 10:24 ET | 1381 | 3.155 |
| 10:26 ET | 200 | 3.155 |
| 10:28 ET | 200 | 3.1564 |
| 10:30 ET | 3400 | 3.16 |
| 10:32 ET | 2800 | 3.16 |
| 10:33 ET | 800 | 3.16 |
| 10:37 ET | 300 | 3.165 |
| 10:39 ET | 1200 | 3.15 |
| 10:42 ET | 500 | 3.15 |
| 10:44 ET | 100 | 3.145 |
| 10:46 ET | 297 | 3.1491 |
| 10:48 ET | 400 | 3.14 |
| 10:50 ET | 100 | 3.14 |
| 10:53 ET | 100 | 3.14 |
| 10:55 ET | 2100 | 3.145 |
| 10:57 ET | 100 | 3.14 |
| 11:00 ET | 100 | 3.145 |
| 11:02 ET | 100 | 3.14 |
| 11:04 ET | 500 | 3.13 |
| 11:06 ET | 4091 | 3.135 |
| 11:08 ET | 2261 | 3.1399 |
| 11:11 ET | 3699 | 3.13 |
| 11:13 ET | 600 | 3.13 |
| 11:15 ET | 200 | 3.13 |
| 11:18 ET | 200 | 3.138 |
| 11:22 ET | 200 | 3.13 |
| 11:27 ET | 100 | 3.13 |
| 11:29 ET | 100 | 3.13 |
| 11:33 ET | 100 | 3.13 |
| 11:36 ET | 100 | 3.13 |
| 11:38 ET | 100 | 3.13 |
| 11:40 ET | 1700 | 3.13 |
| 11:42 ET | 17768 | 3.13 |
| 11:44 ET | 1289 | 3.13 |
| 11:45 ET | 200 | 3.13 |
| 11:47 ET | 6700 | 3.13 |
| 11:49 ET | 5750 | 3.13 |
| 11:51 ET | 1780 | 3.12 |
| 11:54 ET | 1350 | 3.1199 |
| 11:56 ET | 100 | 3.1199 |
| 12:00 ET | 200 | 3.115 |
| 12:02 ET | 100 | 3.11 |
| 12:03 ET | 100 | 3.11 |
| 12:05 ET | 6773 | 3.095 |
| 12:07 ET | 11035 | 3.11 |
| 12:09 ET | 5098 | 3.095 |
| 12:12 ET | 900 | 3.095 |
| 12:14 ET | 1792 | 3.095 |
| 12:16 ET | 4386 | 3.11 |
| 12:18 ET | 2800 | 3.105 |
| 12:20 ET | 2970 | 3.101 |
| 12:21 ET | 2300 | 3.1 |
| 12:23 ET | 200 | 3.1 |
| 12:25 ET | 404 | 3.1099 |
| 12:27 ET | 198 | 3.1 |
| 12:30 ET | 396 | 3.1 |
| 12:32 ET | 3245 | 3.1 |
| 12:34 ET | 200 | 3.1 |
| 12:36 ET | 6168 | 3.1099 |
| 12:38 ET | 8221 | 3.12 |
| 12:39 ET | 8269 | 3.13 |
| 12:41 ET | 4814 | 3.135 |
| 12:43 ET | 1030 | 3.13 |
| 12:45 ET | 545 | 3.135 |
| 12:48 ET | 310 | 3.135 |
| 12:50 ET | 837 | 3.135 |
| 12:52 ET | 224 | 3.135 |
| 12:54 ET | 213 | 3.135 |
| 12:56 ET | 549 | 3.135 |
| 12:57 ET | 410 | 3.135 |
| 12:59 ET | 1019 | 3.135 |
| 01:01 ET | 312 | 3.135 |
| 01:03 ET | 1666 | 3.1309 |
| 01:06 ET | 465 | 3.135 |
| 01:08 ET | 538 | 3.135 |
| 01:10 ET | 244 | 3.135 |
| 01:12 ET | 671 | 3.135 |
| 01:14 ET | 313 | 3.135 |
| 01:15 ET | 524 | 3.135 |
| 01:17 ET | 241 | 3.135 |
| 01:19 ET | 530 | 3.135 |
| 01:21 ET | 4701 | 3.125 |
| 01:24 ET | 398 | 3.125 |
| 01:26 ET | 846 | 3.125 |
| 01:28 ET | 525 | 3.125 |
| 01:30 ET | 1117 | 3.13 |
| 01:32 ET | 819 | 3.125 |
| 01:33 ET | 701 | 3.125 |
| 01:35 ET | 735 | 3.125 |
| 01:37 ET | 440 | 3.125 |
| 01:39 ET | 300 | 3.125 |
| 01:42 ET | 320 | 3.13 |
| 01:44 ET | 465 | 3.125 |
| 01:46 ET | 410 | 3.13 |
| 01:48 ET | 513 | 3.125 |
| 01:50 ET | 741 | 3.13 |
| 01:51 ET | 440 | 3.125 |
| 01:53 ET | 1416 | 3.13 |
| 01:55 ET | 2108 | 3.125 |
| 01:57 ET | 327 | 3.13 |
| 02:00 ET | 1435 | 3.125 |
| 02:02 ET | 445 | 3.13 |
| 02:04 ET | 1505 | 3.125 |
| 02:06 ET | 612 | 3.125 |
| 02:08 ET | 739 | 3.13 |
| 02:09 ET | 563 | 3.125 |
| 02:11 ET | 703 | 3.13 |
| 02:13 ET | 737 | 3.13 |
| 02:15 ET | 3934 | 3.13 |
| 02:18 ET | 468 | 3.125 |
| 02:20 ET | 235 | 3.125 |
| 02:22 ET | 1217 | 3.13 |
| 02:24 ET | 444 | 3.13 |
| 02:26 ET | 440 | 3.125 |
| 02:27 ET | 1611 | 3.13 |
| 02:29 ET | 846 | 3.13 |
| 02:31 ET | 3457 | 3.15 |
| 02:33 ET | 580 | 3.145 |
| 02:36 ET | 601 | 3.145 |
| 02:38 ET | 342 | 3.15 |
| 02:40 ET | 550 | 3.145 |
| 02:42 ET | 424 | 3.145 |
| 02:44 ET | 414 | 3.15 |
| 02:45 ET | 221 | 3.145 |
| 02:47 ET | 3986 | 3.15 |
| 02:49 ET | 326 | 3.145 |
| 02:51 ET | 37914 | 3.165 |
| 02:54 ET | 900 | 3.165 |
| 02:56 ET | 380 | 3.165 |
| 03:00 ET | 320 | 3.165 |
| 03:02 ET | 884 | 3.165 |
| 03:03 ET | 840 | 3.165 |
| 03:05 ET | 1495 | 3.165 |
| 03:07 ET | 900 | 3.165 |
| 03:09 ET | 8822 | 3.145 |
| 03:12 ET | 322 | 3.145 |
| 03:14 ET | 1366 | 3.145 |
| 03:16 ET | 966 | 3.145 |
| 03:18 ET | 329 | 3.145 |
| 03:20 ET | 1236 | 3.145 |
| 03:21 ET | 1972 | 3.15 |
| 03:23 ET | 803 | 3.15 |
| 03:25 ET | 469 | 3.145 |
| 03:27 ET | 809 | 3.145 |
| 03:32 ET | 481 | 3.145 |
| 03:34 ET | 491 | 3.145 |
| 03:36 ET | 1641 | 3.145 |
| 03:38 ET | 9483 | 3.17 |
| 03:39 ET | 383 | 3.165 |
| 03:43 ET | 486 | 3.165 |
| 03:45 ET | 4944 | 3.18 |
| 03:48 ET | 1455 | 3.175 |
| 03:50 ET | 100 | 3.175 |
| 03:52 ET | 2829 | 3.175 |
| 03:54 ET | 10678 | 3.18 |
| 03:56 ET | 17218 | 3.1912 |
| 03:57 ET | 11028 | 3.2 |
| 03:59 ET | 11322 | 3.2 |
Yesterday
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 11:16AM ET on Thursday May 16, 2024 by Dow Jones
11:16AM ET on Thursday May 16, 2024 by Dow JonesDJ Mereo BioPharma Group Price Target Maintained With a $6.00/Share by Needham, from 7:33AM ET on Thursday May 16, 2024 by Dow Jones
7:33AM ET on Thursday May 16, 2024 by Dow Jones
May 15, 2024
Press Release: Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow JonesMereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 458.7M | -12.1x | --- |
Third Harmonic Bio Inc | 579.4M | -14.7x | --- |
Cabaletta Bio Inc | 590.7M | -7.1x | --- |
Northwest Biotherapeutics Inc | 579.9M | -8.1x | --- |
Oculis Holding AG | 498.5M | -6.6x | --- |
Compass Pathways PLC | 546.4M | -3.3x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $458.7M |
|---|---|
Revenue (TTM) | $9.0M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.70 |
EPS | $-0.26 |
Book Value | $0.63 |
P/E Ratio | -12.1x |
Price/Sales (TTM) | 50.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
